Navigation Links
LeMaitre Vascular Reports Q3 2007 Revenue of $10.1 Million, a 19% Increase
Date:11/5/2007

p>

2007 2006 2007 2006

Net sales $10,144 $8,540 $30,342 $25,871

Cost of sales 2,563 2,279 7,778 7,205

Gross profit 7,581 6,261 22,564 18,666

Operating expenses:

Sales and marketing 4,583 3,525 14,131 10,639

General and administrative 2,341 1,536 6,917 5,050

Research and development 1,144 805 3,416 2,586

Distributor termination

costs 1,054 - 1,054 -

Restructuring charges - 53 5 231

Impairment charge - - 7 406

Total operating expenses 9,122 5,919 25,530 18,912

Income (loss) from operations (1,541) 342 (2,966) (246)

Other income (expense):

Interest income (expense) 359 (175) 1,054 (275)

Other income 221 21 275 152

Total other income (loss) 580 (154) 1,329 (123)

Income (loss) before income

taxes (961) 188 (1,637) (369)

Provision (benefit) for income

taxes 393 (33) 119 129

Net income (loss) $(1,354) $221 $(1,756) $(498)

Net income (loss) per share of

common stock:

Basic $(0.09) $0.01 $(0.11) $(0.09)

Diluted $(0.09) $0.01 $(0.11) $(0.09)

Weighted average shares

outstanding:

Basic 15,410 8,497 15,376 8,497

Diluted 15,410 8,904
'/>"/>

SOURCE LeMaitre Vascular, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. LeMaitre Vascular to Start Italian Sales Force
2. LeMaitre Vascular to Participate at CIBC 18th Annual Healthcare Conference
3. Antioxidants show no clear benefit against cardiovascular events, death in high-risk women
4. Waist-to-hip ratio may better predict cardiovascular risk than body mass index
5. Pot bellies linked to early signs of cardiovascular disease
6. Air pollution linked to cardiovascular risk indices in healthy young adults
7. Environmental stress probed in cardiovascular disease, diabetes
8. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
9. American Heart Association Enhances eLearning for Emergency Cardiovascular Care (ECC)
10. Researchers provide genetic associations from a genome-wide scan for cardiovascular disease traits
11. GrantAdler Shipping Novel Implantable Vascular Access Port
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Plainsboro, NJ (PRWEB) January 22, 2015 ... advocate and keynote speaker at the upcoming 32nd ... by ACCME-accredited Physicians’ Education Resource®, LLC (PER®) , ... breast would have gone undetected if she had not ...
(Date:1/22/2015)... 22, 2015 Yesterday, Senator Holly ... and Kristin Olsen (R-Modesto) were honored by the ... advancing biotechnology, biomedical science, medical device and pharmaceutical ... received the “2014 Life Sciences Champion” award from ...
(Date:1/22/2015)... January 22, 2015 IsoComforter, Inc. has introduced ... with patented IsoTube design to treat specific body parts and ... most progressive and easy to use patented cold therapy machine ... sports related orthopedic and muscle injuries. IsoComforter has become ...
(Date:1/22/2015)... Payday lending practices in four southern states ... distress to the states that permit them, according to ... on Race and Wealth. , While they generate hundreds ... at the same time substantially depress economic activity, according ...
(Date:1/22/2015)... NY (PRWEB) January 22, 2015 As interest ... overall health care gains momentum worldwide, Rev. Eric J. ... HealthCare Chaplaincy Network (HCCN), will be the keynote speaker ... care in Israel’s public health system. , The conference, “Hope ...
Breaking Medicine News(10 mins):Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3
... Reporter , TUESDAY, July 13 (HealthDay News) -- During ... members of the U.S. government panel that could decide the ... A decision on whether to ban Avandia or not ... that the drug,s maker, GlaxoSmithKline, may have buried or manipulated ...
... The decision regarding treatment following breast-conserving surgery for patients ... an area of discussion and confusion for patients and ... low, the risk of local recurrence in the breast ... and hormone treatment. While both treatments have been ...
... July 15, 2010 An immune-system protein already used to ... of cancers might also aid asthma patients, UT Southwestern Medical ... the protein interferon blocks the development of a population of ... of a class of T lymphocytes, called T helper 2 ...
... of Mississippi Medical Center and four collaborating academic medical ... of Health to identify risk factors for Alzheimer,s disease ... Mosley, UMMC professor of geriatric medicine and one of ... will pay for the ARIC Neurocognitive Study, a comprehensive ...
... Reporter , TUESDAY, July 13 (HealthDay News) -- Patients ... symptoms frequently attributed to memory problems or difficulty finding ... brain disorder may also have a reduced ability to ... from the University of Florida and other institutions showed ...
... Tolstoy portrayed Russians as a brooding, complicated people, and ... dark feelings and memories more than Westerners do. But ... though Russians tend to brood, they are less likely ... "Among Westerners, focusing on one,s negative feelings tends ...
Cached Medicine News:Health News:FDA Panel Seems Skeptical Over Key Avandia Data 2Health News:FDA Panel Seems Skeptical Over Key Avandia Data 3Health News:FDA Panel Seems Skeptical Over Key Avandia Data 4Health News:Prediction tool helps estimate local recurrence in patients with noninvasive breast cancer 2Health News:Prediction tool helps estimate local recurrence in patients with noninvasive breast cancer 3Health News:Interferon might help asthma patients breathe easier, UT Southwestern study suggests 2Health News:University of Mississippi Medical Center to lead in nationwide NIH-funded Alzheimer's study 2Health News:University of Mississippi Medical Center to lead in nationwide NIH-funded Alzheimer's study 3Health News:Emotions May Be Blunted in Alzheimer's Patients 2Health News:Emotions May Be Blunted in Alzheimer's Patients 3Health News:Brooding Russians: Less distressed than Americans 2
(Date:1/23/2015)... Jan. 23, 2015  HyGreen, Inc., a leader in hand ... with RCA Medical, a subsidiary of Ascendis Health Limited, ... Each year, hundreds of millions of patients around ... organisms are transmitted from patient to patient via the ...
(Date:1/23/2015)... N.Y. , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. ... its Phase I trial of Lixte,s lead compound, LB‑100, is ... John S. Kovach , M.D., the founder ... planned to be completed at a single site. Accrual of ...
(Date:1/23/2015)... Jan. 23, 2015  CytoSorbents Corporation (NASDAQ CM: CTSO), ... extracorporeal cytokine adsorber to reduce deadly inflammation in ... of $385,642, net of transaction costs, in non-dilutive ... Business Tax Certificate Transfer Program sponsored by the ...
Breaking Medicine Technology:HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3
To maintain the conjunctival cul-de-sacs after enucleation or evisceration without hindering lid closure....
To maintain the conjunctival cul-de-sacs after enucleation or evisceration without hindering lid closure....
... plugs are coated with a ... that makes the surface slick ... and to prevent debris from ... partial occlusion. For partial stenosis. ...
With side bite Instrument recommended to catch the polypropylene thread in the nose....
Medicine Products: